Home/Indapta Therapeutics/John Sunwoo, M.D.

JS

John Sunwoo, M.D.

Scientific Founder

Indapta Therapeutics

Therapeutic Areas

Oncology Autoimmune Diseases

Indapta Therapeutics Pipeline

Drug	Indication	Phase
G-NK cells + mAb	Relapsed/Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma	Phase 1
G-NK cells	Multiple Sclerosis	Phase 1

Leadership Team at Indapta Therapeutics

Mark W. Frohlich, M.D.

Chief Executive Officer

Chief Operating Officer & Co-Founder

Chairman of the Board and Co-Founder

Sungjin Kim, Ph.D.

Scientific Founder

View full Indapta Therapeutics profile